Based on the report from Kita et al. (62), PIK3CA mutations in primary (directly diagnosed as glioblastoma) or secondary (originated from low-grade gliomas) glioblastoma were 4.7% (5 out of 107) or 3.1% (1 out of 32), respectively. Here, PIK3CA is linked to glioblastoma.